Figure 1.

Summary of the design and results of the current study. This study included 4 major components: 1) meta‐analysis of genome‐wide association study of circulating sclerostin; 2) single trait genetic analysis and functional annotation of the top sclerostin signals; 3) Mendelian randomization and genetic correlation analysis of sclerostin on 15 atherosclerosis‐related diseases and risk factors traits; 4) bidirectional Mendelian randomization analysis of 15 atherosclerosis‐related diseases and risk factors on sclerostin. SNPs = single‐nucleotide polymorphisms; HDL‐C = high‐density lipoprotein cholesterol.